NR4A1 and breast cancer: Therefore, we performed a pooled participant-level analysis of multiple clinical trials and cohorts to evaluate the overall association between RCB and long-term outcomes, with emphasis on the breast cancer subtypes defined by hormone receptor and HER2 receptor status.